ProPhase Labs, Inc.
PRPH
$0.3513
$0.041113.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.77M | 3.35M | 8.57M | 19.32M | 34.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.77M | 3.35M | 8.57M | 19.32M | 34.98M |
| Cost of Revenue | 6.92M | 8.17M | 10.89M | 14.71M | 19.43M |
| Gross Profit | -150.00K | -4.81M | -2.32M | 4.60M | 15.56M |
| SG&A Expenses | 37.89M | 29.42M | 30.01M | 32.74M | 33.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.40M | 38.37M | 42.13M | 49.71M | 56.20M |
| Operating Income | -38.63M | -35.02M | -33.56M | -30.39M | -21.22M |
| Income Before Tax | -42.33M | -37.63M | -35.32M | -31.79M | -22.40M |
| Income Tax Expenses | 7.20M | -10.28M | -9.41M | -8.60M | -6.02M |
| Earnings from Continuing Operations | -49.53 | -27.35 | -25.91 | -23.20 | -16.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.36M | -27.76M | -26.31M | -23.60M | -16.78M |
| EBIT | -38.63M | -35.02M | -33.56M | -30.39M | -21.22M |
| EBITDA | -32.44M | -27.71M | -26.85M | -23.95M | -15.17M |
| EPS Basic | -2.61 | -1.52 | -1.47 | -1.35 | -0.97 |
| Normalized Basic EPS | -1.28 | -1.29 | -1.24 | -1.14 | -0.81 |
| EPS Diluted | -2.62 | -1.53 | -1.48 | -1.36 | -0.97 |
| Normalized Diluted EPS | -1.28 | -1.29 | -1.24 | -1.14 | -0.81 |
| Average Basic Shares Outstanding | 76.48M | 73.22M | 71.32M | 69.27M | 67.98M |
| Average Diluted Shares Outstanding | 76.48M | 73.22M | 71.32M | 69.27M | 69.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |